Microfluidics: The tiny, beautiful tech hidden all around you

When you think of micro- or nanotechnology, you likely think of small electronics like your phone, a tiny robot or a microchip. But COVID-19 tests—which have proven to be central to controlling the pandemic—are also a ...

Actavis buying Warner Chilcott in $8.5B deal

Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.

Research advances on transplant ward pathogen

The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year—mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant. It's difficult to treat ...

Study of phytoremediation benefits of 86 indoor plants published

Formaldehyde is a major contaminant of indoor air, originating from particle board, carpet, window coverings, paper products, tobacco smoke, and other sources. Indoor volatile organic compounds (VOCs) such as formaldehyde ...

Cell component involved in triggering cat allergy

(PhysOrg.com) -- A breakthrough by scientists at The University of Nottingham could provide hope for any allergy sufferers who have ever had to choose between their health and their household pet.

New insights into asthma drug development

Asthma is one of the most common chronic respiratory diseases worldwide and its prevalence is on the rise. Epidemiological studies reveal that the incidence of asthma ranges from 1% to 18% in various countries. More than ...

Researchers discover new therapeutic target for severe asthma

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) have uncovered a new approach for treating severe asthma. They have high hopes their discovery may pave the ...

page 4 from 8